'Vaginal Laser Therapy for GSM/VVA: Where We Stand Now - A Review by the EUGA Working Group on Laser'
Climacteric. 2023 Oct 2:1-2. doi: 10.1080/13697137.2023.2259791. Online ahead of print.NO ABSTRACTPMID:37782251 | DOI:10.1080/13697137.2023.2259791 (Source: Climacteric)
Source: Climacteric - October 2, 2023 Category: Geriatrics Authors: F G Li J A Abbott Source Type: research

'Vaginal Laser Therapy for GSM/VVA: Where We Stand Now - A Review by the EUGA Working Group on Laser'
Climacteric. 2023 Oct 2:1-2. doi: 10.1080/13697137.2023.2259791. Online ahead of print.NO ABSTRACTPMID:37782251 | DOI:10.1080/13697137.2023.2259791 (Source: Climacteric)
Source: Climacteric - October 2, 2023 Category: Geriatrics Authors: F G Li J A Abbott Source Type: research

'Vaginal Laser Therapy for GSM/VVA: Where We Stand Now - A Review by the EUGA Working Group on Laser'
Climacteric. 2023 Oct 2:1-2. doi: 10.1080/13697137.2023.2259791. Online ahead of print.NO ABSTRACTPMID:37782251 | DOI:10.1080/13697137.2023.2259791 (Source: Climacteric)
Source: Climacteric - October 2, 2023 Category: Geriatrics Authors: F G Li J A Abbott Source Type: research

'Vaginal Laser Therapy for GSM/VVA: Where We Stand Now - A Review by the EUGA Working Group on Laser'
Climacteric. 2023 Oct 2:1-2. doi: 10.1080/13697137.2023.2259791. Online ahead of print.NO ABSTRACTPMID:37782251 | DOI:10.1080/13697137.2023.2259791 (Source: Climacteric)
Source: Climacteric - October 2, 2023 Category: Geriatrics Authors: F G Li J A Abbott Source Type: research

'Vaginal Laser Therapy for GSM/VVA: Where We Stand Now - A Review by the EUGA Working Group on Laser'
Climacteric. 2023 Oct 2:1-2. doi: 10.1080/13697137.2023.2259791. Online ahead of print.NO ABSTRACTPMID:37782251 | DOI:10.1080/13697137.2023.2259791 (Source: Climacteric)
Source: Climacteric - October 2, 2023 Category: Geriatrics Authors: F G Li J A Abbott Source Type: research

'Vaginal Laser Therapy for GSM/VVA: Where We Stand Now - A Review by the EUGA Working Group on Laser'
Climacteric. 2023 Oct 2:1-2. doi: 10.1080/13697137.2023.2259791. Online ahead of print.NO ABSTRACTPMID:37782251 | DOI:10.1080/13697137.2023.2259791 (Source: Climacteric)
Source: Climacteric - October 2, 2023 Category: Geriatrics Authors: F G Li J A Abbott Source Type: research

'Vaginal Laser Therapy for GSM/VVA: Where We Stand Now - A Review by the EUGA Working Group on Laser'
Climacteric. 2023 Oct 2:1-2. doi: 10.1080/13697137.2023.2259791. Online ahead of print.NO ABSTRACTPMID:37782251 | DOI:10.1080/13697137.2023.2259791 (Source: Climacteric)
Source: Climacteric - October 2, 2023 Category: Geriatrics Authors: F G Li J A Abbott Source Type: research

'Vaginal Laser Therapy for GSM/VVA: Where We Stand Now - A Review by the EUGA Working Group on Laser'
Climacteric. 2023 Oct 2:1-2. doi: 10.1080/13697137.2023.2259791. Online ahead of print.NO ABSTRACTPMID:37782251 | DOI:10.1080/13697137.2023.2259791 (Source: Climacteric)
Source: Climacteric - October 2, 2023 Category: Geriatrics Authors: F G Li J A Abbott Source Type: research

A disease of her own? Unique features of heart failure in women
Climacteric. 2023 Sep 28:1-9. doi: 10.1080/13697137.2023.2256673. Online ahead of print.ABSTRACTHeart failure (HF) is a significant and growing public health challenge for women. Compared with men, women tend to develop HF later in life and are more likely to experience HF with preserved ejection fraction. There are also significant sex differences in outcomes, with women reporting lower quality of life but overall better survival versus men. In this review, we summarize sex differences in traditional HF risk factors, such as hypertension, diabetes, obesity and coronary artery disease, as well as female-specific HF risk fa...
Source: Climacteric - September 28, 2023 Category: Geriatrics Authors: W A Spacht E S Lau Source Type: research

Reproductive milestones across the lifespan and cardiovascular disease risk in women
Climacteric. 2023 Sep 28:1-11. doi: 10.1080/13697137.2023.2259793. Online ahead of print.ABSTRACTCardiovascular disease (CVD) is the leading cause of death for women across the developed and developing world. Beyond traditional cardiovascular risk factors, a number of reproductive milestones have been recognized. The goal of this White Paper, issued by the International Menopause Society in conjunction with World Menopause Day 2023, is to highlight female reproductive milestones in terms of potential cardiovascular risk and to review recommendations for minimizing that risk. The primary milestones discussed relate to menst...
Source: Climacteric - September 28, 2023 Category: Geriatrics Authors: C A Stuenkel Source Type: research

A disease of her own? Unique features of heart failure in women
Climacteric. 2023 Sep 28:1-9. doi: 10.1080/13697137.2023.2256673. Online ahead of print.ABSTRACTHeart failure (HF) is a significant and growing public health challenge for women. Compared with men, women tend to develop HF later in life and are more likely to experience HF with preserved ejection fraction. There are also significant sex differences in outcomes, with women reporting lower quality of life but overall better survival versus men. In this review, we summarize sex differences in traditional HF risk factors, such as hypertension, diabetes, obesity and coronary artery disease, as well as female-specific HF risk fa...
Source: Climacteric - September 28, 2023 Category: Geriatrics Authors: W A Spacht E S Lau Source Type: research

Reproductive milestones across the lifespan and cardiovascular disease risk in women
Climacteric. 2023 Sep 28:1-11. doi: 10.1080/13697137.2023.2259793. Online ahead of print.ABSTRACTCardiovascular disease (CVD) is the leading cause of death for women across the developed and developing world. Beyond traditional cardiovascular risk factors, a number of reproductive milestones have been recognized. The goal of this White Paper, issued by the International Menopause Society in conjunction with World Menopause Day 2023, is to highlight female reproductive milestones in terms of potential cardiovascular risk and to review recommendations for minimizing that risk. The primary milestones discussed relate to menst...
Source: Climacteric - September 28, 2023 Category: Geriatrics Authors: C A Stuenkel Source Type: research

A disease of her own? Unique features of heart failure in women
Climacteric. 2023 Sep 28:1-9. doi: 10.1080/13697137.2023.2256673. Online ahead of print.ABSTRACTHeart failure (HF) is a significant and growing public health challenge for women. Compared with men, women tend to develop HF later in life and are more likely to experience HF with preserved ejection fraction. There are also significant sex differences in outcomes, with women reporting lower quality of life but overall better survival versus men. In this review, we summarize sex differences in traditional HF risk factors, such as hypertension, diabetes, obesity and coronary artery disease, as well as female-specific HF risk fa...
Source: Climacteric - September 28, 2023 Category: Geriatrics Authors: W A Spacht E S Lau Source Type: research

Reproductive milestones across the lifespan and cardiovascular disease risk in women
Climacteric. 2023 Sep 28:1-11. doi: 10.1080/13697137.2023.2259793. Online ahead of print.ABSTRACTCardiovascular disease (CVD) is the leading cause of death for women across the developed and developing world. Beyond traditional cardiovascular risk factors, a number of reproductive milestones have been recognized. The goal of this White Paper, issued by the International Menopause Society in conjunction with World Menopause Day 2023, is to highlight female reproductive milestones in terms of potential cardiovascular risk and to review recommendations for minimizing that risk. The primary milestones discussed relate to menst...
Source: Climacteric - September 28, 2023 Category: Geriatrics Authors: C A Stuenkel Source Type: research

A disease of her own? Unique features of heart failure in women
Climacteric. 2023 Sep 28:1-9. doi: 10.1080/13697137.2023.2256673. Online ahead of print.ABSTRACTHeart failure (HF) is a significant and growing public health challenge for women. Compared with men, women tend to develop HF later in life and are more likely to experience HF with preserved ejection fraction. There are also significant sex differences in outcomes, with women reporting lower quality of life but overall better survival versus men. In this review, we summarize sex differences in traditional HF risk factors, such as hypertension, diabetes, obesity and coronary artery disease, as well as female-specific HF risk fa...
Source: Climacteric - September 28, 2023 Category: Geriatrics Authors: W A Spacht E S Lau Source Type: research